Article
Alzheimer's disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II.
The Journal of biological chemistry - 1 Mar 2026
Salvo Miranda A, Cuddy Leah K, Prokopenko Dmitry, Watkins Elyse, Tanzi Rudolph E, Vassar Robert
Abstract excerpt
Angiotensin-converting enzyme (ACE) is a validated risk locus for developing late-onset Alzheimer's disease (AD). Although ACE1 expression and enzyme activity correlate with AD diagnosis, the mechanism by which this occurs is unclear. As a cell membrane-bound and shed peptidase, ACE1 is most commonly known to produce angiotensin II (Ang II), which has been linked to AD pathogenesis but also has been shown to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
